16 |
2026 |
Accuracy at the Degradation Product Level pharm. |
Natuli |
7.09.2010 |
9:41 |
3 |
215 |
Adjusted Gradient Profile pharm. |
Natuli |
6.09.2010 |
23:19 |
2 |
229 |
Recovery precision was evaluated by the two-day spike pharm. |
Natuli |
6.09.2010 |
22:26 |
6 |
448 |
baseline drift and spectral, offsets segment/ gap spectr. |
Natuli |
6.09.2010 |
7:59 |
4 |
253 |
Ring-Opened и proMABA chem. |
Natuli |
5.09.2010 |
17:30 |
10 |
974 |
poor resolution of early eluting peaks chromat. |
Natuli |
4.09.2010 |
22:31 |
2 |
1155 |
Standard Preparation Variability, vial-to-vial variability pharm. |
Natuli |
4.09.2010 |
13:52 |
1 |
386 |
HPLC Assay, Degradates,Content Uniformity and Identity Method pharm. |
Natuli |
4.09.2010 |
8:32 |
9 |
571 |
biowaver is justified and matrix effects by excipients pharm. |
Natuli |
24.08.2010 |
10:06 |
4 |
173 |
New submission Russia pharm. |
Natuli |
24.08.2010 |
9:54 |
4 |
179 |
bulk harmonization process triggered by pharm. |
Natuli |
24.08.2010 |
8:16 |
2 |
202 |
suspension forms pharm. |
Natuli |
18.08.2010 |
0:33 |
5 |
692 |
Lab head QC2-QBP QA/QC QBP pharm. |
Natuli |
31.07.2010 |
22:53 |
4 |
198 |
after thawning/ carpoules pharm. |
Natuli |
31.07.2010 |
22:23 |
4 |
638 |
contract manufacturer, performs a duty of care check pharm. |
Natuli |
30.07.2010 |
7:51 |
3 |
294 |
bioidentity: cell proliferation assay: absolute IC50 beetween 70-120% of IC50 at a time of release pharm. |
Natuli |
30.07.2010 |
7:50 |
2 |
327 |
Total of any peaks eluted before the principal chromat. |
Natuli |
29.07.2010 |
23:18 |
3 |
212 |
your letter/your initials |
Natuli |
29.07.2010 |
12:11 |
3 |
255 |
diffuse main band corresponding to the single band pharm. |
Natuli |
29.07.2010 |
10:24 |
3 |
508 |
disodium hydrogen phosphate -dehydrate pharm. |
Natuli |
29.07.2010 |
10:08 |
2 |
161 |
Head regulatory ROW GROUP pharm. |
Natuli |
29.07.2010 |
8:15 |
3 |
415 |
multiple strengths pharm. |
Natuli |
29.07.2010 |
8:14 |
8 |
1150 |
T.D. manager, Dr.ssa |
Natuli |
25.07.2010 |
11:30 |
7 |
568 |
Shipment under ice pharm. |
Natuli |
25.07.2010 |
11:25 |
5 |
184 |
linear. pharm. |
Natuli |
18.07.2010 |
19:19 |
2 |
311 |
applies legally binding pharmacopeia limits and registered product specifications pharm. |
Natuli |
18.07.2010 |
18:52 |
4 |
229 |
Assessment of relative statistical control pharm. |
Natuli |
18.07.2010 |
9:09 |
9 |
1217 |
Hardness, Dissolution, Breakage, pharm. |
Natuli |
17.07.2010 |
15:28 |
3 |
201 |
established product /historical review pharm. |
Natuli |
17.07.2010 |
12:34 |
3 |
174 |
repeatable, stable and robust pharm. |
Natuli |
17.07.2010 |
11:28 |
5 |
247 |
PURITY BY SODIUM HYDROXIDE TITRATION pharm. |
Natuli |
14.07.2010 |
9:25 |